These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

806 related articles for article (PubMed ID: 20829328)

  • 1. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
    Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
    Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heading in a new direction: drug permeability in breast cancer brain metastasis.
    Sledge GW
    Clin Cancer Res; 2010 Dec; 16(23):5605-7. PubMed ID: 21045085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
    Arvanitis CD; Askoxylakis V; Guo Y; Datta M; Kloepper J; Ferraro GB; Bernabeu MO; Fukumura D; McDannold N; Jain RK
    Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8717-E8726. PubMed ID: 30150398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks.
    Palmieri D; Lockman PR; Thomas FC; Hua E; Herring J; Hargrave E; Johnson M; Flores N; Qian Y; Vega-Valle E; Taskar KS; Rudraraju V; Mittapalli RK; Gaasch JA; Bohn KA; Thorsheim HR; Liewehr DJ; Davis S; Reilly JF; Walker R; Bronder JL; Feigenbaum L; Steinberg SM; Camphausen K; Meltzer PS; Richon VM; Smith QR; Steeg PS
    Clin Cancer Res; 2009 Oct; 15(19):6148-57. PubMed ID: 19789319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.
    Lyle LT; Lockman PR; Adkins CE; Mohammad AS; Sechrest E; Hua E; Palmieri D; Liewehr DJ; Steinberg SM; Kloc W; Izycka-Swieszewska E; Duchnowska R; Nayyar N; Brastianos PK; Steeg PS; Gril B
    Clin Cancer Res; 2016 Nov; 22(21):5287-5299. PubMed ID: 27245829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomodulators targeting endothelial WNT and pericytes to reversibly open the blood-tumor barrier for boosted brain tumor therapy.
    Mu R; Sun H; Zeng Y; Tong Y; Tang P; Zhao M; Lv Z; Yu J; Chen Y; Lan Q; Zhen X; Han L
    J Control Release; 2024 May; 369():458-474. PubMed ID: 38575077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases.
    Gril B; Paranjape AN; Woditschka S; Hua E; Dolan EL; Hanson J; Wu X; Kloc W; Izycka-Swieszewska E; Duchnowska R; Pęksa R; Biernat W; Jassem J; Nayyar N; Brastianos PK; Hall OM; Peer CJ; Figg WD; Pauly GT; Robinson C; Difilippantonio S; Bialecki E; Metellus P; Schneider JP; Steeg PS
    Nat Commun; 2018 Jul; 9(1):2705. PubMed ID: 30006619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model.
    Park EJ; Zhang YZ; Vykhodtseva N; McDannold N
    J Control Release; 2012 Nov; 163(3):277-84. PubMed ID: 23000189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2 antibody-drug conjugate controls growth of breast cancer brain metastases in hematogenous xenograft models, with heterogeneous blood-tumor barrier penetration unlinked to a passive marker.
    Gril B; Wei D; Zimmer AS; Robinson C; Khan I; Difilippantonio S; Overstreet MG; Steeg PS
    Neuro Oncol; 2020 Nov; 22(11):1625-1636. PubMed ID: 32386414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.
    Adkins CE; Mohammad AS; Terrell-Hall TB; Dolan EL; Shah N; Sechrest E; Griffith J; Lockman PR
    Clin Exp Metastasis; 2016 Apr; 33(4):373-83. PubMed ID: 26944053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement in blood-tumor barrier permeability and delivery of liposomal doxorubicin using focused ultrasound and microbubbles: evaluation during tumor progression in a rat glioma model.
    Aryal M; Park J; Vykhodtseva N; Zhang YZ; McDannold N
    Phys Med Biol; 2015 Mar; 60(6):2511-27. PubMed ID: 25746014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study.
    Nounou MI; Adkins CE; Rubinchik E; Terrell-Hall TB; Afroz M; Vitalis T; Gabathuler R; Tian MM; Lockman PR
    Pharm Res; 2016 Dec; 33(12):2930-2942. PubMed ID: 27528392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prodrug Delivery Using Dual-Targeting Nanoparticles To Treat Breast Cancer Brain Metastases.
    Ju X; Chen H; Miao T; Ni J; Han L
    Mol Pharm; 2021 Jul; 18(7):2694-2702. PubMed ID: 34109794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of KCa channels increases anticancer drug delivery to brain tumors and prolongs survival in xenograft model.
    Ningaraj NS; Sankpal UT; Khaitan D; Meister EA; Vats TS
    Cancer Biol Ther; 2009 Oct; 8(20):1924-33. PubMed ID: 19738431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lnc00462717 regulates the permeability of the blood-brain tumor barrier through interaction with PTBP1 to inhibit the miR-186-5p/Occludin signaling pathway.
    Zhang C; Zhang X; Wang J; Di F; Xue Y; Lin X; Zhang Y; Zhang H; Zhang Z; Gu Y
    FASEB J; 2020 Aug; 34(8):9941-9958. PubMed ID: 32623796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis.
    Gril B; Palmieri D; Qian Y; Smart D; Ileva L; Liewehr DJ; Steinberg SM; Steeg PS
    Clin Cancer Res; 2011 Jan; 17(1):142-53. PubMed ID: 21081656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer.
    Mohammad AS; Adkins CE; Shah N; Aljammal R; Griffith JIG; Tallman RM; Jarrell KL; Lockman PR
    BMC Cancer; 2018 Dec; 18(1):1225. PubMed ID: 30526520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Preclinical Model of Brain Metastases of Breast Cancer.
    Samala R; Thorsheim HR; Goda S; Taskar K; Gril B; Steeg PS; Smith QR
    Pharm Res; 2016 Dec; 33(12):2904-2919. PubMed ID: 27541873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer.
    Wu SK; Chiang CF; Hsu YH; Lin TH; Liou HC; Fu WM; Lin WL
    Int J Nanomedicine; 2014; 9():4485-94. PubMed ID: 25278753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.
    Mohammad AS; Griffith JI; Adkins CE; Shah N; Sechrest E; Dolan EL; Terrell-Hall TB; Hendriks BS; Lee H; Lockman PR
    Pharm Res; 2018 Jan; 35(2):31. PubMed ID: 29368289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.